PREDIERI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.319
EU - Europa 19.719
AS - Asia 4.716
SA - Sud America 220
AF - Africa 124
OC - Oceania 118
Continente sconosciuto - Info sul continente non disponibili 14
Totale 46.230
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.063
IT - Italia 10.302
GB - Regno Unito 3.927
SE - Svezia 1.499
CN - Cina 1.467
SG - Singapore 1.277
DE - Germania 1.047
UA - Ucraina 737
HK - Hong Kong 715
FR - Francia 571
TR - Turchia 502
FI - Finlandia 416
BG - Bulgaria 295
IN - India 201
IE - Irlanda 143
CA - Canada 137
CH - Svizzera 126
ID - Indonesia 117
AU - Australia 103
BR - Brasile 93
IR - Iran 82
ES - Italia 76
JP - Giappone 76
BZ - Belize 73
RU - Federazione Russa 73
BE - Belgio 70
NL - Olanda 70
VN - Vietnam 63
LT - Lituania 60
DK - Danimarca 55
EG - Egitto 55
MY - Malesia 50
CZ - Repubblica Ceca 47
EC - Ecuador 44
MX - Messico 37
PL - Polonia 34
RO - Romania 33
KR - Corea 29
PK - Pakistan 27
TH - Thailandia 25
PT - Portogallo 24
VE - Venezuela 24
AR - Argentina 21
GR - Grecia 21
TW - Taiwan 19
ZA - Sudafrica 17
PE - Perù 16
NZ - Nuova Zelanda 15
IQ - Iraq 14
EU - Europa 13
RS - Serbia 13
SM - San Marino 13
HU - Ungheria 11
PH - Filippine 10
ET - Etiopia 9
SA - Arabia Saudita 9
CL - Cile 8
KW - Kuwait 8
NO - Norvegia 8
AT - Austria 7
CO - Colombia 7
MA - Marocco 7
MT - Malta 7
NG - Nigeria 7
DZ - Algeria 6
EE - Estonia 6
SI - Slovenia 6
IL - Israele 5
LK - Sri Lanka 5
GH - Ghana 4
HR - Croazia 4
KE - Kenya 4
UG - Uganda 4
UY - Uruguay 4
CR - Costa Rica 3
ME - Montenegro 3
MK - Macedonia 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BT - Bhutan 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
MD - Moldavia 2
NA - Namibia 2
OM - Oman 2
TD - Ciad 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CM - Camerun 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
Totale 46.218
Salva come PNG Salva come JPEG
Città #
Southend 3.321
Fairfield 2.253
Chandler 1.624
Woodbridge 1.600
Houston 1.517
Ashburn 1.428
Santa Clara 1.406
Jacksonville 1.354
Dearborn 1.130
Singapore 1.034
Nyköping 888
Ann Arbor 859
Seattle 816
Wilmington 801
Milan 708
Cambridge 686
Hong Kong 667
Rome 659
Beijing 422
Princeton 325
Sofia 282
Naples 272
Eugene 253
Bologna 250
Modena 250
San Diego 247
New York 235
Redwood City 217
Helsinki 212
Izmir 206
Palermo 202
Turin 185
Bremen 184
San Jose 177
Bari 126
Catania 117
Shanghai 113
Padova 112
London 108
Dublin 105
Florence 104
Jakarta 98
Fremont 97
Des Moines 93
Parma 91
Verona 87
Boardman 82
Albuquerque 76
Belize City 73
Falls Church 70
Las Vegas 70
Genoa 63
Dong Ket 61
Dallas 53
Nanjing 53
Norwalk 52
Brescia 50
Pescara 50
Frankfurt am Main 47
Toronto 47
Hefei 44
Cagliari 43
Reggio Nell'emilia 41
Guangzhou 40
Brussels 39
Torino 39
Munich 38
Odense 38
Brno 37
Kunming 37
Paris 37
Saint Louis 36
Menlo Park 34
Napoli 34
Treviso 34
Cairo 32
Bergamo 31
Caserta 31
Pavia 31
Philadelphia 31
Perugia 30
Chicago 29
Columbus 29
Mumbai 29
Reggio Emilia 29
Ottawa 28
Phoenix 28
Salerno 28
Grafing 27
Ankara 26
Novellara 26
Leawood 25
Augusta 24
Dongguan 24
Pisa 24
Tehran 24
Messina 23
Portici 23
San Mateo 23
Wuhan 23
Totale 30.017
Salva come PNG Salva come JPEG
Nome #
CASO CLINICO: SINDROME DA MICRODELEZIONE 16p11.2 PROSSIMALE 4.003
Diabete tipo 2 e obesità pediatrica: rassegna a cura dei Gruppi di Studio Obesità Infantile e Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica 947
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 783
I DISORDINI DELLO SVILUPPO SESSUALE E LE MALFORMAZIONI DELL’APPARATO GENITALE 738
Gestione del Covid-19 in età pediatrica: documento di consenso 628
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 574
Effetti degli interferenti endocrini su crescita e sviluppo puberale 513
Si può “Valere” di più: un progetto italiano studia i disturbi alimentari negli adolescenti con diabete tipo 1. Dati preliminari 511
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 390
BODY EMOTIONAL MAP: STRUMENTO INNOVATIVO ED UTILE PER MIGLIORARE L’ADATTAMENTO DEI GENITORI ALLA DIAGNOSI DI DIABETE DI TIPO 1 DEL LORO BAMBINO 349
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 343
Hypospadias: clinical approach, surgical technique and outcome. Twenty years’ experience of a single centre 314
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 301
Oral Administration of Lactobacillus Reuteri Improves Periodontal Disease in Children and Adolescents with Type 1 Diabetes 296
Effects of Exercise in Children and Adolescent with Type 1 Diabetes Mellitus 271
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 261
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 261
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting 258
Childhood obesity and environmental pollutants: a dual relationship 253
DETERMINANTI DELLA HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ADOLESCENTI OBESI ITALIANI 249
MALATTIA PARODONTALE IN BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1: EFFICACIA DELLA SOMMINISTRAZIONE ORALE DI LACTOBACILLUS REUTERI 248
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 245
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 243
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 234
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 230
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 230
Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0-18 years 230
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 225
L’ipercolesterolemia familiare: terapia farmacologica 218
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 214
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 213
Dolore addominale acuto nelle adolescenti: le principali patologie di natura ginecologica 210
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study 207
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program 205
Alti livelli di anticorpi antitransglutaminasi predicono la malattia celiaca in bambini e adolescenti italiani con diabete mellito tipo 1. 202
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study 200
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes. 199
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 198
Plasma brain-derived neurotrophic factor concentrations in children and adolescents. 194
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 194
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. 193
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry 192
Confocal microscopy: Improving our understanding of nevogenesis 190
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 190
Rhabdomyoma of a rare type in a child: Case report and literature review 188
Complex disease phenotype revealed by GH deficiency associated with a novel and unusual defect in the GH-1 gene. 186
Novel insights on the treatment of hypercholesterolemia 183
Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients 183
Brain-derived neurotrophic factor and epilepsy: a systematic review 182
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 182
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 181
Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. 181
A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes 180
Hypercholesterolemia in Childhood 180
Relationship between body mass index and insulin measured during oral glucose tolerance testing in severely obese children and adolescents 179
High basal serum allopregnanolone levels in overweight girls 178
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy 177
Glycemic Control in Kenyan Children and Adolescents with Type 1 Diabetes Mellitus 175
Obesity in pediatric age: The analysis of genomic rearrangements 175
Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report 173
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 172
Iper CPKemia, non solo miopatie 172
Tracheobronchial anomalies in chromosome 22q11.2 microdeletion 171
High serum allopregnanolone levels in girls with precocious puberty 170
Evaluation and management of hyperlipidemia in children and adolescents. 170
Impaired GH Secretion in Patients with SHOX Deficiency and Efficacy of Recombinant Human GH Therapy. 170
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 170
Approaches to dyslipidemia treatment in children and adolescents. 169
Endocrine Disrupting Chemicals and Type 1 Diabetes 168
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 166
Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian study. 164
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 163
High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes 163
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 163
Pharmacological treatment of obesity in children and adolescents: present and future. 162
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease. 162
Ten-Year Longitudinal Study of Thyroid Function in Children with Down's Syndrome 162
Thyroid function in Down syndrome 162
Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study 162
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 162
High levels of serum perfluorinated compounds in children and adolescents with endocrine autoimmune disease 162
Low-density lipoprotein oxidizability in children with chronic renal failure 161
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 161
Low serum allopregnanolone levels in girls with precocious pubarche 159
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. 159
COVID-19 and Type 1 Diabetes: Concerns and Challenges 159
SHORT STATURE HOMEOBOX-CONTAINING GENE AND IDIOPATHIC SHORT STATURE 158
Continuous subcutaneous insulin infusion in Italy: third national survey 156
In children with autoimmune thyroid diseases the association with Down syndrome can modify the clustering of extra-thyroidal autoimmune disorders 156
Unexpected phenotype in a boy with trisomy of the SHOX gene. 156
Younger age at diagnosis of type 1 diabetes mellitus in children of immigrated families born in Italy. 155
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 154
Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: A review 153
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 153
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 152
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 149
In Children with Autoimmune Thyroid Diseases the Association with Down syndrome can Modify the Clustering of Extra-Thyroidal Autoimmune Disorders 149
Gli interferenti endocrini 146
High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity 145
Obesity in patients with acute lymphoblastic leukemia in childhood. 143
Totale 26.639
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 162.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.690 0 0 0 0 731 1.124 1.246 848 640 351 487 263
2020/20217.088 611 223 516 833 729 541 952 630 405 694 549 405
2021/20226.054 208 655 466 561 343 392 309 405 625 466 933 691
2022/20237.655 723 631 466 588 825 923 366 760 927 382 600 464
2023/20247.290 389 447 495 698 983 694 585 870 416 427 571 715
2024/20254.362 572 469 440 1.066 1.815 0 0 0 0 0 0 0
Totale 47.024